276 related articles for article (PubMed ID: 19803478)
41. Radiosynthesis and evaluation of a
Vats K; Subramanian S; Mathur A; Sarma HD; Banerjee S
Bioorg Med Chem Lett; 2017 Mar; 27(5):1329-1332. PubMed ID: 28174106
[TBL] [Abstract][Full Text] [Related]
42. The therapeutic efficiency of FP-PEA/TAM67 gene complexes via folate receptor-mediated endocytosis in a xenograft mice model.
Arote RB; Hwang SK; Lim HT; Kim TH; Jere D; Jiang HL; Kim YK; Cho MH; Cho CS
Biomaterials; 2010 Mar; 31(8):2435-45. PubMed ID: 20022105
[TBL] [Abstract][Full Text] [Related]
43. In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer.
Müller C; Schubiger PA; Schibli R
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1162-70. PubMed ID: 16721570
[TBL] [Abstract][Full Text] [Related]
44. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
Chen YC; Chang WH; Wang SJ; Hsieh WY
J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
[TBL] [Abstract][Full Text] [Related]
45. Folate receptor-directed orthogonal click-functionalization of siRNA lipopolyplexes for tumor cell killing in vivo.
Klein PM; Kern S; Lee DJ; Schmaus J; Höhn M; Gorges J; Kazmaier U; Wagner E
Biomaterials; 2018 Sep; 178():630-642. PubMed ID: 29580727
[TBL] [Abstract][Full Text] [Related]
46. Folic acid-conjugated europium complexes as luminescent probes for selective targeting of cancer cells.
Quici S; Casoni A; Foschi F; Armelao L; Bottaro G; Seraglia R; Bolzati C; Salvarese N; Carpanese D; Rosato A
J Med Chem; 2015 Feb; 58(4):2003-14. PubMed ID: 25602505
[TBL] [Abstract][Full Text] [Related]
47. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical.
Wang S; Luo J; Lantrip DA; Waters DJ; Mathias CJ; Green MA; Fuchs PL; Low PS
Bioconjug Chem; 1997; 8(5):673-9. PubMed ID: 9327130
[TBL] [Abstract][Full Text] [Related]
48. Preclinical Comparison of Albumin-Binding Radiofolates: Impact of Linker Entities on the in Vitro and in Vivo Properties.
Siwowska K; Haller S; Bortoli F; Benešová M; Groehn V; Bernhardt P; Schibli R; Müller C
Mol Pharm; 2017 Feb; 14(2):523-532. PubMed ID: 28094532
[TBL] [Abstract][Full Text] [Related]
49. 18 F-click labeling and preclinical evaluation of a new 18 F-folate for PET imaging.
Schieferstein H; Betzel T; Fischer CR; Ross TL
EJNMMI Res; 2013 Sep; 3(1):68. PubMed ID: 24041035
[TBL] [Abstract][Full Text] [Related]
50. Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor.
Nkepang G; Bio M; Rajaputra P; Awuah SG; You Y
Bioconjug Chem; 2014 Dec; 25(12):2175-88. PubMed ID: 25351441
[TBL] [Abstract][Full Text] [Related]
51.
Ma W; Fu F; Zhu J; Huang R; Zhu Y; Liu Z; Wang J; Conti PS; Shi X; Chen K
Nanoscale; 2018 Mar; 10(13):6113-6124. PubMed ID: 29547220
[TBL] [Abstract][Full Text] [Related]
52. Polyfluorene nanoparticles coated with folate-functionalized triblock copolymer: effective agents for targeted cell imaging.
Liu L; Patra A; Scherf U; Kissel T
Macromol Biosci; 2012 Oct; 12(10):1384-90. PubMed ID: 22926969
[TBL] [Abstract][Full Text] [Related]
53. Folic acid conjugates for nuclear imaging of folate receptor-positive cancer.
Müller C; Schibli R
J Nucl Med; 2011 Jan; 52(1):1-4. PubMed ID: 21149477
[TBL] [Abstract][Full Text] [Related]
54. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
55. Combined muta- and semisynthesis: a powerful synthetic hybrid approach to access target specific antitumor agents based on ansamitocin P3.
Taft F; Harmrolfs K; Nickeleit I; Heutling A; Kiene M; Malek N; Sasse F; Kirschning A
Chemistry; 2012 Jan; 18(3):880-6. PubMed ID: 22170289
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM
J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.
Leamon CP; Parker MA; Vlahov IR; Xu LC; Reddy JA; Vetzel M; Douglas N
Bioconjug Chem; 2002; 13(6):1200-10. PubMed ID: 12440854
[TBL] [Abstract][Full Text] [Related]
58. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation.
Rossin R; Pan D; Qi K; Turner JL; Sun X; Wooley KL; Welch MJ
J Nucl Med; 2005 Jul; 46(7):1210-8. PubMed ID: 16000291
[TBL] [Abstract][Full Text] [Related]
59. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
[TBL] [Abstract][Full Text] [Related]
60. Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors.
Reddy JA; Xu LC; Parker N; Vetzel M; Leamon CP
J Nucl Med; 2004 May; 45(5):857-66. PubMed ID: 15136637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]